304 related articles for article (PubMed ID: 35248719)
1. m
Shen M; Guo M; Li Y; Wang Y; Qiu Y; Shao J; Zhang F; Xu X; Yin G; Wang S; Chen A; Zhang Z; Zheng S
Free Radic Biol Med; 2022 Mar; 182():246-259. PubMed ID: 35248719
[TBL] [Abstract][Full Text] [Related]
2. N
Shen M; Li Y; Wang Y; Shao J; Zhang F; Yin G; Chen A; Zhang Z; Zheng S
Redox Biol; 2021 Nov; 47():102151. PubMed ID: 34607160
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells.
Zhang Z; Wang X; Wang Z; Zhang Z; Cao Y; Wei Z; Shao J; Chen A; Zhang F; Zheng S
Biofactors; 2021 Sep; 47(5):801-818. PubMed ID: 34129254
[TBL] [Abstract][Full Text] [Related]
4. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells.
Zhang Z; Guo M; Li Y; Shen M; Kong D; Shao J; Ding H; Tan S; Chen A; Zhang F; Zheng S
Autophagy; 2020 Aug; 16(8):1482-1505. PubMed ID: 31679460
[TBL] [Abstract][Full Text] [Related]
6. Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis.
Zhang Z; Yao Z; Zhao S; Shao J; Chen A; Zhang F; Zheng S
Cell Death Dis; 2017 Jun; 8(6):e2886. PubMed ID: 28617435
[TBL] [Abstract][Full Text] [Related]
7. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Wang L; Zhang Z; Li M; Wang F; Jia Y; Zhang F; Shao J; Chen A; Zheng S
IUBMB Life; 2019 Jan; 71(1):45-56. PubMed ID: 30321484
[TBL] [Abstract][Full Text] [Related]
8. ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis.
Zhang Z; Guo M; Zhao S; Shao J; Zheng S
Free Radic Biol Med; 2016 Dec; 101():272-283. PubMed ID: 27989749
[TBL] [Abstract][Full Text] [Related]
9. The blockade of lipophagy pathway is necessary for docosahexaenoic acid to regulate lipid droplet turnover in hepatic stellate cells.
Qiu S; Xu H; Lin Z; Liu F; Tan F
Biomed Pharmacother; 2019 Jan; 109():1841-1850. PubMed ID: 30551439
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway.
Chen Q; Chen L; Wu X; Zhang F; Jin H; Lu C; Shao J; Kong D; Wu L; Zheng S
IUBMB Life; 2016 Mar; 68(3):220-31. PubMed ID: 26865509
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin inhibits the activation and proliferation of hepatic stellate cells by regulating miR‑29b‑3p.
Huan S; Sun S; Song S; Dai J; Zhu G; Zhong Y; Ji Y; Zheng S; Yin G
Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37026504
[TBL] [Abstract][Full Text] [Related]
13. Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway.
Kong Z; Liu R; Cheng Y
Biomed Pharmacother; 2019 Jan; 109():2043-2053. PubMed ID: 30551460
[TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.
Xu W; Lu C; Zhang F; Shao J; Zheng S
IUBMB Life; 2016 May; 68(5):376-87. PubMed ID: 27027402
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway.
Yuan S; Wei C; Liu G; Zhang L; Li J; Li L; Cai S; Fang L
Cell Prolif; 2022 Jan; 55(1):e13158. PubMed ID: 34811833
[TBL] [Abstract][Full Text] [Related]
16. Wogonoside attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis through SOCS1/P53/SLC7A11 pathway.
Liu G; Wei C; Yuan S; Zhang Z; Li J; Zhang L; Wang G; Fang L
Phytother Res; 2022 Nov; 36(11):4230-4243. PubMed ID: 35817562
[TBL] [Abstract][Full Text] [Related]
17. HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT/GPX4 axis.
Tan Y; Huang Y; Mei R; Mao F; Yang D; Liu J; Xu W; Qian H; Yan Y
Cell Death Dis; 2022 Apr; 13(4):319. PubMed ID: 35395830
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11.
Lang Z; Yu S; Hu Y; Tao Q; Zhang J; Wang H; Zheng L; Yu Z; Zheng J
Phytomedicine; 2023 Sep; 118():154950. PubMed ID: 37441987
[TBL] [Abstract][Full Text] [Related]
19. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
Sui M; Jiang X; Chen J; Yang H; Zhu Y
Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
[TBL] [Abstract][Full Text] [Related]
20. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S
Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
